<DOC>
	<DOCNO>NCT00113165</DOCNO>
	<brief_summary>This study conduct compare efficacy safety LAMICTAL ( lamotrigine ) extended-release placebo treatment partial seizure . LAMICTAL extended-release investigational drug . Placebo tablet look like LAMICTAL extended-release tablet contain active medication . In study , LAMICTAL extended-release placebo tablet add current seizure treatment .</brief_summary>
	<brief_title>Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Inclusion criterion : Diagnosis epilepsy partial seizure 24 week . Must experience least 8 partial seizure 8week Baseline Phase . Must currently receive treatment stable regimen one two antiepileptic drug least four week . Patient parent/caregiver must willing able maintain write daily seizure diary . Exclusion criterion : Previous treatment lamotrigine . Exhibits primary generalized seizure . Receiving treatment felbamate currently follow ketogenic diet . Pregnant , breastfeeding , plan become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>partial seizure</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>antiepileptic drug</keyword>
	<keyword>anticonvulsant</keyword>
	<keyword>LAMICTAL</keyword>
	<keyword>seizure</keyword>
	<keyword>lamotrigine</keyword>
</DOC>